Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics

This study aimed to provide comparative information of pharmaceutical properties, including particle morphology and distribution uniformity, solubility, presence of residual solvent and insoluble particles, and antimicrobial activities, between brand-name meropenem (Mepem<sup>®</sup>, BN...

Full description

Bibliographic Details
Main Authors: Ping Yang, Shigeru Fujimura, Yawei Du, Bei Zhang, Li Yang, Masato Kawamura, Zhenhua Zhang, Suodi Zhai
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/10/9/1096
_version_ 1797520460890505216
author Ping Yang
Shigeru Fujimura
Yawei Du
Bei Zhang
Li Yang
Masato Kawamura
Zhenhua Zhang
Suodi Zhai
author_facet Ping Yang
Shigeru Fujimura
Yawei Du
Bei Zhang
Li Yang
Masato Kawamura
Zhenhua Zhang
Suodi Zhai
author_sort Ping Yang
collection DOAJ
description This study aimed to provide comparative information of pharmaceutical properties, including particle morphology and distribution uniformity, solubility, presence of residual solvent and insoluble particles, and antimicrobial activities, between brand-name meropenem (Mepem<sup>®</sup>, BNM) and its six generic products (GPs A-F) marketed in China. Particles of GP-A and -C in dry powder had similar diameters of BNM, while other GPs were larger. Only BNM and GP-A were completely dissolved within 100 s in the lab condition. No insoluble particles >25 μm in diameter were detected in BNM and GP-E. Regarding stability of GPs solutions evaluated by concentration of open-ring metabolites at 6 h and 8 h, BNM showed the lowest open-ringed metabolite concentrates. Residual solvent of acetone detected in one GP showed the maximum value, while ethanol and ethyl acetate were detected both in product E and product F. The concordance rates (%) of minimum inhibitory concentration (MIC) of each generic compared to BNM were 89.5, 85, 87.5, 88, 88.5, and 86.5, respectively, although no significant difference was reached in MIC. Pharmaceutical characteristic differences between the BNM and GPs identified in this study could provide insights into understanding the deviations in the drug manufacturing processes of generic drugs.
first_indexed 2024-03-10T07:57:05Z
format Article
id doaj.art-6db52b4d3759460081d7af24e4ab860b
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T07:57:05Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-6db52b4d3759460081d7af24e4ab860b2023-11-22T11:46:12ZengMDPI AGAntibiotics2079-63822021-09-01109109610.3390/antibiotics10091096Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its GenericsPing Yang0Shigeru Fujimura1Yawei Du2Bei Zhang3Li Yang4Masato Kawamura5Zhenhua Zhang6Suodi Zhai7Department of Pharmacy, Peking University Third Hospital, Beijing 100191, ChinaDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, JapanDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, ChinaDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, JapanDepartment of Medical Affairs, Sumitomo Pharmaceuticals (Suzhou) Co. Ltd., Shanghai 200025, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, ChinaThis study aimed to provide comparative information of pharmaceutical properties, including particle morphology and distribution uniformity, solubility, presence of residual solvent and insoluble particles, and antimicrobial activities, between brand-name meropenem (Mepem<sup>®</sup>, BNM) and its six generic products (GPs A-F) marketed in China. Particles of GP-A and -C in dry powder had similar diameters of BNM, while other GPs were larger. Only BNM and GP-A were completely dissolved within 100 s in the lab condition. No insoluble particles >25 μm in diameter were detected in BNM and GP-E. Regarding stability of GPs solutions evaluated by concentration of open-ring metabolites at 6 h and 8 h, BNM showed the lowest open-ringed metabolite concentrates. Residual solvent of acetone detected in one GP showed the maximum value, while ethanol and ethyl acetate were detected both in product E and product F. The concordance rates (%) of minimum inhibitory concentration (MIC) of each generic compared to BNM were 89.5, 85, 87.5, 88, 88.5, and 86.5, respectively, although no significant difference was reached in MIC. Pharmaceutical characteristic differences between the BNM and GPs identified in this study could provide insights into understanding the deviations in the drug manufacturing processes of generic drugs.https://www.mdpi.com/2079-6382/10/9/1096meropenemdissolution timestabilitymorphology of particlesantimicrobial susceptibility patterns
spellingShingle Ping Yang
Shigeru Fujimura
Yawei Du
Bei Zhang
Li Yang
Masato Kawamura
Zhenhua Zhang
Suodi Zhai
Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
Antibiotics
meropenem
dissolution time
stability
morphology of particles
antimicrobial susceptibility patterns
title Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
title_full Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
title_fullStr Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
title_full_unstemmed Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
title_short Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
title_sort comparison of pharmaceutical characteristics between brand name meropenem and its generics
topic meropenem
dissolution time
stability
morphology of particles
antimicrobial susceptibility patterns
url https://www.mdpi.com/2079-6382/10/9/1096
work_keys_str_mv AT pingyang comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics
AT shigerufujimura comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics
AT yaweidu comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics
AT beizhang comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics
AT liyang comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics
AT masatokawamura comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics
AT zhenhuazhang comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics
AT suodizhai comparisonofpharmaceuticalcharacteristicsbetweenbrandnamemeropenemanditsgenerics